ArticleScientific reports2022
Preparation and catalytic application of two different nanocatalysts based on hexagonal mesoporous silica (HMS) in synthesis of tetrahydrobenzo[b]pyran and 1,4-dihydropyrano[2,3-c]pyrazole derivatives.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Design and catalytic performance of a novel two-dimensional copper metal-organic framework for green synthesis of tetrahydrobenzo[b]pyrans.Scientific reports · 2025Article
- Article
- Design of natural asphalt sulfamic acid (NA-NHSOHeliyon · 2025Article
- Article
- Magnetic curcumin-copper graphene oxide as facile and recyclable heterogeneous nanocatalyst for preparation of polyhydroquinolines and sulfoxides.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study describes the synthesis, characterization, and investigation of catalytic activity of xanthine-Ni complex (Xa-Ni) and 4-phenylthiosemicarbazide-Cu complex (PTSC-Cu) incorporated into functionalized hexagonal mesoporous silica (HMS/Pr-Xa-Ni and HMS/Pr-PTSC-Cu). These useful mesoporous catalysts had been synthesized and identified using various techniques such as FT-IR, XRD, adsorption-desorption of nitrogen, SEM, TEM, EDX-Map, TGA, AAS and ICP. These spectral techniques successfully confirmed the synthesis of the mesoporous catalysts. The catalytic activity of HMS/Pr-a-Ni (Catalyst A) and HMS/Pr-PTSC-Cu (Catalyst B) were evaluated for synthesis of tetrahydrobenzo[b]pyran and 1,4-dihydropyrano[2,3-c]pyrazole derivatives. HMS/Pr-PTSC-Cu exhibited higher efficiency in green media under milder reaction condition at room temperature. Furthermore, the synthesized nanocatalysts, exhibited appropriate recoverability that can be able to reuse for several times without significant loss of catalytic activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.